Core A. Clinical examines the natural history of senile dementia of the Alzheimer type (SDAT) and healthy aging in longitudinal samples of carefully assessed subjects, using established clinical, cognitive, and neurological methods. The Core also recruits, evaluates, and supplies subjects to the individual projects in this renewal application. Clinicopathological correlations are enhanced by the Core's emphasis on obtaining autopsy permission from both nondemented and demented subjects. Data from these Core activities are compared, with the assistance of Core D. Biostatistics, with those from Core B. Psychometrics, Core C. Neuropathology, and all Projects to explore the central theme of the Program Project: the behavioral and biomedical correlates of SDAT in comparison with healthy aging. These objectives build on our previous studies in these areas. The study of very old persons (aged 80 years and over) will be expanded by enrolling additional subjects and serially assessing them until autopsy to examine areas of overlap in advanced aging and Alzheimer's disease. Core clinical data, including information obtained by a Retrospective Collateral Dementia Interview in brains obtained from the Body Donor Program or General Autopsy Service, will be correlated with detailed patho-anatomic mapping of markers of neuronal degeneration. Attentional factor affecting memory processing in aging and dementia and the effects of hypoglycemia on memory performance will be studied in Core subjects. The Core will continue to enroll subjects in the very mild stages of SDAT and follow its established samples of subjects, originally entered as controls, to distinguish the earliest clinical manifestations of disease from changes associated with aging and to identify those factors predictive of SDAT.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
3P01AG003991-18S1
Application #
6481832
Study Section
Project Start
2001-08-01
Project End
2001-12-31
Budget Start
Budget End
Support Year
18
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
La Joie, Renaud; Bejanin, Alexandre; Fagan, Anne M et al. (2018) Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology 90:e282-e290
Roe, Catherine M; Babulal, Ganesh M; Stout, Sarah H et al. (2018) Using the A/T/N Framework to Examine Driving in Preclinical AD. Geriatrics (Basel) 3:
Swarup, Vivek; Hinz, Flora I; Rexach, Jessica E et al. (2018) Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. Nat Med :
Suárez-Calvet, Marc; Capell, Anja; Araque Caballero, Miguel Ángel et al. (2018) CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. EMBO Mol Med 10:
Bussy, Aurélie; Snider, B Joy; Coble, Dean et al. (2018) Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network. Neurobiol Aging 75:42-50
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Su, Yi; Flores, Shaney; Hornbeck, Russ C et al. (2018) Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. Neuroimage Clin 19:406-416
Kawamura, Naoki; Yokota, Tatsuya; Hontani, Hidekata (2018) Super-Resolution of Magnetic Resonance Images via Convex Optimization with Local and Global Prior Regularization and Spectrum Fitting. Int J Biomed Imaging 2018:9262847
Cruchaga, Carlos; Del-Aguila, Jorge L; Saef, Benjamin et al. (2018) Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14:205-214
Maxwell, Taylor J; Corcoran, Chris; Del-Aguila, Jorge L et al. (2018) Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels. Alzheimers Res Ther 10:86

Showing the most recent 10 out of 911 publications